Although brain and bone metastases appeared numerically more frequent in the KRAS G12C subgroup, these differences did not reach statistical significance (all p > 0.05).
← all excerpts
Clinicopathological Characteristics and Prognostic Impact of KRAS Mutations in Non-Small Cell Lung Cancer.
1
0.0500
0.0500